4-iodophenyl isothiocyanate: A neuroprotective compound

Restorative Neurology and Neuroscience

Volumn 30, Issue 1, 2012, Pages 21-38

  Wellejus, Anja ^a   Elbrønd Bek, Heidi ^a   Kelly, Nicholas M ^a   Weidner, Morten S ^a   Jørgensen, Signe H ^a  

^a Nensius Research A/S   (Denmark)

Author keywords

4 iodophenyl isothiocyanate; EAE; excitotoxicity; MPTP; neuroprotection; reactive oxygen species

Indexed keywords

1 METHYLPHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 IODOPHENYL ISOTHIOCYANATE; ANTIINFLAMMATORY AGENT; DOPAMINE; GLUCOSE; GLUTAMIC ACID; ISOTHIOCYANIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; OXYGEN; PYRIDINIUM DERIVATIVE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE DEGENERATION; NERVE FIBER GROWTH; NESTING; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; CELLS, CULTURED; CEREBRAL CORTEX; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; GLUCOSE; GLUTAMIC ACID; HERBICIDES; IODOBENZENES; ISOTHIOCYANATES; L-LACTATE DEHYDROGENASE; MONOAMINE OXIDASE; N-METHYLASPARTATE; NEURITES; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; PEROXIDES; PROTEIN BINDING; RATS; RATS, WISTAR;

EID: 84858207203     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: 10.3233/RNN-2011-0617     Document Type: Article

References (51)

1. Brandenburg, L.-O., Kipp, M., Lucius, R., Pufe, T. & Wruck, C.J. (2010). Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm Res, 59, 443-450.
2. Callaway, E.C., Zhang, Y., Chew, W. & Sherry Chow, H.-H. (2004). Cellular accumulation of dietary anticarcinogenic isothiocyanates is followed by transporter-mediated export as dithiocarbamates. Cancer Lett, 204, 23-31. (Pubitemid 38117190)
3. Camelo, S., Iglesias, A.H., Hwang, D., Due, B., Ryu, H., Smith, K., Gray, S.G., Imitola, J., Duran, G., Assaf, B., Langley, B., Khoury, S.J., Stephanopoulos, G., De Girolami, U., Ratan, R.R., Ferrante, R.J. & Dangond, F. (2005). Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol, 164, 10-21. (Pubitemid 40826758)
4. Cao, T.T., Ma, L., Kandpal, G., Warren, L., Hess, J.F. & Seabrook, G.R. (2005). Increased nuclear factor-erythroid 2 p45-related factor 2 activity protects SH-SY5Y cells against oxidative damage. J Neurochem, 95, 406-417. (Pubitemid 41457509)
5. Chen, P.-S., Peng, G.-S., Li, G., Yang, S., Wu, X., Wang, C.-C., Wilson, B., Lu, R.-B., Gean, P.-W., Chuang, D.-M. & Hong, J.-S. (2006). Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry, 11, 1116-1125. (Pubitemid 44867481)
6. Cheng, Y. & Prusoff, W.H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol, 22(23), 3099-3108.
7. Cheung, K.L. & Kong, A.-N. (2009). Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J, 12(1), 87-97.
8. Clark, D.E. (1999). Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci, 88(8), 815-821. (Pubitemid 29398551)
9. Danilov, C.A., Chandrasekaran, K., Racz, J., Soane, L., Zielke, C. & Fiskum, G. (2009). Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia, 57(6), 645-656.
10. Deacon, R.M.J. (2006). Assessing nest building in mice. Nat Protoc, 1(3), 1117-1119.
11. Ertl, P., Rohde, B. & Selzer, P. (2000). Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem, 43(20), 3714-3717.
12. Ernst, I.M.A., Wagner, A.E., Schuemann, C., Storm, N., Höppner, Döring, F., Stocker, A. & Rimbach, G.(2011). Allyl-, butyland phenylethyl-isothiocyanate activate Nrf2 in cultured fibroblasts. Pharm Res, 63, 233-240.
13. Fahn, S. (1996). The case of the frozen addicts: How the solution of an extraordinary medical mystery spawned a revolution in the understanding and treatment of Parkinson's disease. NEJM, 335(26), 2002-2003.
14. German, D.C., Nelson, E.L., Liang, C.-L., Speciale, S.G., Sinton, C.M. & Sonsalla, P.K. (1996). The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration, 5(4), 299-312. (Pubitemid 27077888)
15. Giros, B. & Caron, M.G. (1993). Molecular characterization of the dopamine transporter. Trends Pharmacol Sci, 14(2), 43-49. (Pubitemid 23049339)
16. Gu, H., Wall, S.C. & Rudnick, G. (1994). Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem, 269(10), 7124-7130. (Pubitemid 24217896)
17. Guerrero-Beltrán, C.E., Calderón-Oliver, M., Pedraza-Chaverri, J. & Chirino, Y.I. (2010). Protective effect of sulforaphane against oxidative stress: Recent advances. Exp Toxicol Pathol, article in press, doi:10.1016/j.etp.2010.11.005.
18. Hu, K. & Morris, M.E. (2004). Effects of benzyl-, phenethyl-, and α-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport. J Pharmacol Sci, 93(7), 1901-1911. (Pubitemid 38823715)
19. Innamorato, N.G., Rojo, A.I., García-Yagüe, A.J., Yamamoto, M., de Ceballos, M.L. & Cuadrado, A. (2008). The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol, 181, 680-689.
20. Jakubíková, J., Sedlák, J., Bod'o, J. & Bao, Y. (2006). Effect of isothiocyanates on nuclear accumulation of NF-κB, Nrf2, and thioredoxin in Caco-2 cells. J Agric Food Chem, 54, 1656-1662.
21. Johnson, D.A., Amirahmadi, S., Ward, C., Fabry, Z. & Johnson, J.A. (2010). The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci, 114(2), 237-246.
22. Kim, B.-R., Hu, R., Keum, Y.-S., Hebbar, V., Shen, G., Nair, S.S. & Tony Kong, A.-N. (2003). Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res, 63, 7520-7525. (Pubitemid 37413497)
23. Konsue, N., Kirkpatrick, J., Kuhnert, N., King, L.J. & Ioannides, C. (2010). Repeated oral administration modulates the pharmacolkinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats. Mol Nutr Food Res, 54, 426-432.
24. Kraft, A.D., Johnson, D.A. & Johnson, J.A. (2004). Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci Res, 56, 652-658.
25. Lee, J.-M., Shih, A.Y., Murphy, T.H. & Johnson, J.A. (2003). NF-E2-related Factor-2 mediates neuroprotection against mitochondrial complex 1 inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem, 278(39), 37948-37956. (Pubitemid 37175325)
26. Lipinski, C.A., Lombardo, F., Dominy, B.W. & Feeney, P.J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev, 23, 3-25. (Pubitemid 27046991)
27. Leobenberg, D., Mehdi Nafissi, V., Antonacci, B. & Waitz, A. (1979). Anthelmintic activity of Sch 20350 in dogs. J Parasitol, 65(2), 233. (Pubitemid 9239472)
28. Lu, Q., Lin, X., Feng, J., Zhao, X., Gallagher, R., Lee, M.Y., Chiao, J.-W. & Liu, D. (2008). Phenelhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways. J Hematol Oncol, 1, 6.
29. Myzak, M.C. & Dashwood, R.H. (2006). Histone deacetylases as targets for dietary cancer preventive agents: Lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr drug targets, 7(4), 443-553.
30. Nian, H., Delage, B., Ho, E. & Dashwood, R.H. (2009). Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: Studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen, 50(3), 213-221.
31. Panitz, E. & Shum, K.L. (1981). Efficacy of P- chlorophenylisothiocyanate (Sch 20350) against parasites of ruminants and horses. J Parasitol, 67(6), 964. (Pubitemid 12108356)
32. Paxinos, G. & Franklin, K.B.J. (Eds). The mouse brain in stereotaxic coordinates, second edition, Academic Press, San Diego, 2001.
33. Ping, Z., Liu, W., Kang, Z., Cai, J., Wang, Q., Cheng, N., Wang, S., Wang, S., Zhang, J.H. & Sun, X. (2010). Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Res, 1343, 178-185.
34. Prawan, A., Saw, C.L.L., Khor, T.O., Keum, Y.-S., Yu, S., Hu, L. & Kong, A.-N. (2009). Anti-NF-KB and anti-inflammatory activities of synthetic isothiocyanates: Effect of chemical structures and cellular signaling. Chem Biol Interact, 179, 202-211.
35. Przedborski, S., Jackson-Lewis, V., Yokoyama, R., Shibata, T., Dawson, V.L. & Dawson, T.M. (1996). Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci U S A, 93, 4565-4571.
36. Schinelli, S., Zuddas, A., Kopin, I.J., Barker, J.L. & di Porzio, U. (1988). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon. J Neurochem, 50(6), 1900-1907.
37. Sharma, C., Sadrieh, L., Priyani, A., Ahmed, M., Hassan, A.H. & Hussain, A. (2010). Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and antiinflammatory properties in human cervical cancer cells. Cancer Epidemiol, (in press). doi:10.1016/j.canep.2010.09.008.
38. Shih, A.Y., Johnson, D.A.,Wong, G., Kraft, A.D., Jiang, L., Erb, H., Johnson, J.A. & Murphy, T.H. (2003). Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci, 23, 3394-3406. (Pubitemid 36531981)
39. Soane, L., Dai, W.L., Fiskum, G. & Bambrick, L.L. (2010). Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation. J Neurosci Res, 88, 1355-1363.
40. Tetko, I.V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P., Palyulin, V.A., Radchenko, E.V., Zefirov, N.S., Makarenko, A.S., Tanchuk, V.Y. & Prokopenko, V.V. (2005). Virtual computational chemistry laboratory - design and description. J Comput Aided Mol Des, 19(6), 453-463. (Pubitemid 41613292)
41. Thejass, P. & Kuttan, G. (2007). Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angiogenesis by downregulating nitric oxide (NO) and tumour necrosis factor-α (TNF-α) production. Nitric Oxide, 16(2), 247-257. (Pubitemid 46149387)
42. Urban, P., Andersen, J.K., Hsu, H.-P.P. & Pompon, D. (1991). Comparative membrane locations and activities of human monoamine oxidases expressed in yeast. FEBS, 286(1,2), 142-146.
43. Van de Waterbeemd, C.A., Camenisch, G., Folkers, G., Chretien, J.R. & Raevsky, O.A. (1998). Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J Drug Target, 6(2), 151-165. (Pubitemid 29033982)
44. Van Horssen, J., Drexhage, J.A.R., Flor, T., Gerritsen, W., van der Valk, P. & de Vries, H.E. (2010). Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med, 49, 1283-1289.
45. Vauzour, D., Buonfiglio, M., Corona, G., Chirafisi, J., Vafeiadou, K., Angeloni, C., Hrelia, S., Hrelia, P. & Spencer, J.P.E. (2010). Sulforaphane protects cortical neurons against 5-S-cysteinyldopamine- induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes. Mol Nutr Food Res, 54, 532-542.
46. Wang, Y., Wang, X., Liu, L. & Wang, X. (2009). HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. Neurosci Lett, 467, 212-216.
47. Xu, K. & Thornalley, P.J. (2001). Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro. Biochem Pharmacol, 61, 165-177. (Pubitemid 32121781)
48. Ye, L. & Zhang, Y. (2001). Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes. Carcinogenesis, 22(12), 1987-1992. (Pubitemid 34065393)
49. Youdim, M.B.H. & Finberg, J.P.M. (1991). New directions in monoamine oxidaseAand B selective inhibitors and substrates. Biochem Pharmacol, 41(2), 155-162.
50. Zhao, J., Kobori, N., Aronowski, J. & Dash, P.K. (2006). Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett, 393, 108-112. (Pubitemid 41821089)
51. Zhao, J., Moore, A.N., Redell, J.B. & Dash, P.K. (2007). Enhancing expression of Nrf2-driven genes protects the blood-brain barrier after brain injury. J Neurosci, 27(38), 10240-10248. (Pubitemid 47450456)